Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis

ABSTRACT: Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung disease with limited therapeutic options. We retrospectively analyzed the effects of a comprehensive 4-week inpatient pulmonary rehabilitation (PR) program in 58 patients with advanced LAM (FEV1: 45 ± 34%predicted, 6-min...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Orphanet J Rare Dis
Egile Nagusiak: Gloeckl, Rainer, Nell, Christoph, Schneeberger, Tessa, Jarosch, Inga, Boensch, Martina, Watz, Henrik, Wirtz, Hubert, Welte, Tobias, Kenn, Klaus, Koczulla, Andreas Rembert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Letter to the Editor
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507679/
https://ncbi.nlm.nih.gov/pubmed/32962746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01540-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak